Amaç & Hipotez:Objective: Paroxetine is a commonly prescribed SSRI that can impair erectile function in animal models via inhibition of nitric oxide synthase (NOS).
📊
Temel Bulgular & Veri:The purpose of this study was to evaluate the impact of co-administering tadalafil with paroxetine on penile NOS levels in rats.Materials and Methods: A total of 30 male Sprague-Dawley rats were divided into 3 groups as control (Group-C), paroxetine (Group-P) and paroxetine plus tadalafil (Group-P+T).
💡
Sonuç & Katkı:Statistical significance level was set at p
🔬Tür:Modelleme & Sayısal Simülasyon
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri
Abstract
Objective: Paroxetine is a commonly prescribed SSRI that can impair erectile function in animal models via inhibition of nitric oxide synthase (NOS). Tadalafil potentiates nitric oxide (NO)-mediated responses in isolated trabecular smooth muscle and penile erection. The purpose of this study was to evaluate the impact of co-administering tadalafil with paroxetine on penile NOS levels in rats.Materials and Methods: A total of 30 male Sprague-Dawley rats were divided into 3 groups as control (Group-C), paroxetine (Group-P) and paroxetine plus tadalafil (Group-P+T). After 28 days of treatment, rats were sacrificed and their penile tissues were harvested for analysis. NOS isoform protein levels and immunoreactivity scores of NOS were assessed. Statistical significance level was set at p
🔖
Bu Makaleye Atıf Yap
BATES, J., PASTUSZAK, A., ALTINAY, S., ÇELİK, D. S., KABASAKAL, L., GÜL, A., SEMERCİÖZ, A., ŞEREFOĞLU, E. C. (2022). Tadalafil Preserves Penile Nitric Oxide Synthase from Detrimental Effect of Paroxetine in Rats. Eurasian Journal of Medicine, Cilt: 51 - Sayı: 1, 60–63. https://ajindex.com/articles/508952
Takayanagi Y, Spira AP, Bienvenu OJ, et al. Antidepressant use and lifetime history of mental disorders in a community sample: results from the Baltimore Epidemiologic Catchment Area Study. J Clin Psychiat 2015
[CrossRef] 2. Montejo AL, Llorca G, Izquierdo JA, Rico-Villademoros F. Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction. J Clin Psychiat 2001
62 Suppl 3: 10-21. 3. Zajecka J, Mitchell S, Fawcett J. Treatment-emergent changes in sexual function with selective serotonin reuptake inhibitors as measured with the Rush Sexual Inventory. Psychopharmacol Bull 1997
Burnett AL, Nelson RJ, Calvin DC, et al. Nitric oxide-dependent penile erection in mice lacking neuronal nitric oxide synthase. Mol Med (Cambridge, Mass) 1996
[CrossRef] 5. Angulo J, Peiro C, Sanchez-Ferrer CF, et al. Differential effects of serotonin reuptake inhibitors on erectile responses, NO-production, and neuronal NO synthase expression in rat corpus cavernosum tissue. Brit J Pharmacol 2001
Huang SA, Lie JD. Phosphodiesterase-5 (PDE5) Inhibitors In the Management of Erectile Dysfunction. PT 2013
Porst H, Glina S, Ralph D, Zeigler H, Wong DG, Woodward B. Durability of response following cessation of tadalafil taken once daily as treatment for erectile dysfunction. J Sex Med 2010
[CrossRef] 9. Kessler RC, Demler O, Frank RG, et al. Prevalence and treatment of mental disorders, 1990 to 2003. N Engl J Med 2005
[CrossRef] 10. Zuvekas SH. Prescription drugs and the changing patterns of treatment for mental disorders, 1996-2001. Health affair (Project Hope) 2005
[CrossRef] 11. Olfson M, Marcus SC. National patterns in antidepressant medication treatment. Arch Gen Psychiatry 2009
[CrossRef] 12. Cherry DK, Woodwell DA, Rechtsteiner EA. National Ambulatory Medical Care Survey: 2005 summary. Adv Data 2007
The Use of Medicines in the United States: Review of 2011: The IMS Institute for Healthcare Informatics. Available from: http:// www. imshealth. com/ ims/ Global/ Content/ Insights/ IMS%20Institute %20 for %20 Healthcare %20. 14. IMS National Prescription Audit PLUS: I